Zimmer Biomet Holdings Inc [NYSE: ZBH] surged by $5.13 during the normal trading session on Thursday and reaching a high of $110.82 during the day while it closed the day at $110.20. The company report on October 10, 2023 at 7:00 AM that Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2023 Financial Results.
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Tuesday, November 7, 2023 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.
The live audio webcast can be accessed via Zimmer Biomet’s Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the conference call.
Zimmer Biomet Holdings Inc stock has also gained 6.87% of its value over the past 7 days. However, ZBH stock has declined by -12.76% in the 3 months of the year. Over the past six months meanwhile, it has lost -19.34% and lost -13.57% year-on date.
The market cap for ZBH stock reached $23.03 billion, with 209.00 million shares outstanding and 208.49 million shares in the current float. Compared to the average trading volume of 1.69M shares, ZBH reached a trading volume of 3030287 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Zimmer Biomet Holdings Inc [ZBH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZBH shares is $144.14 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZBH stock is a recommendation set at 2.48. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH MKM have made an estimate for Zimmer Biomet Holdings Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on October 20, 2023.
The Average True Range (ATR) for Zimmer Biomet Holdings Inc is set at 2.57, with the Price to Sales ratio for ZBH stock in the period of the last 12 months amounting to 3.20. The Price to Book ratio for the last quarter was 1.86, with the Price to Cash per share for the same quarter was set at 1.53. Price to Free Cash Flow for ZBH in the course of the last twelve months was 29.15 with Quick ratio for the last quarter at 0.95.
ZBH stock trade performance evaluation
Zimmer Biomet Holdings Inc [ZBH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.87. With this latest performance, ZBH shares gained by 0.46% in over the last four-week period, additionally sinking by -19.34% over the last 6 months – not to mention a drop of -1.47% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZBH stock in for the last two-week period is set at 56.38, with the RSI for the last a single of trading hit 68.10, and the three-weeks RSI is set at 49.76 for Zimmer Biomet Holdings Inc [ZBH]. The present Moving Average for the last 50 days of trading for this stock 112.70, while it was recorded at 105.26 for the last single week of trading, and 126.96 for the last 200 days.
Zimmer Biomet Holdings Inc [ZBH]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Zimmer Biomet Holdings Inc [ZBH] shares currently have an operating margin of +17.34 and a Gross Margin at +62.52. Zimmer Biomet Holdings Inc’s Net Margin is presently recorded at +4.18.
Return on Total Capital for ZBH is now 6.34, given the latest momentum, and Return on Invested Capital for the company is 1.63. Return on Equity for this stock inclined to 2.35, with Return on Assets sitting at 1.30. When it comes to the capital structure of this company, Zimmer Biomet Holdings Inc [ZBH] has a Total Debt to Total Equity ratio set at 49.22. Additionally, ZBH Total Debt to Total Capital is recorded at 32.99, with Total Debt to Total Assets ending up at 28.09. Long-Term Debt to Equity for the company is recorded at 44.25, with the Long-Term Debt to Total Capital now at 29.66.
Reflecting on the efficiency of the workforce at the company, Zimmer Biomet Holdings Inc [ZBH] managed to generate an average of $16,122 per employee. Receivables Turnover for the company is 4.98 with a Total Asset Turnover recorded at a value of 0.31.Zimmer Biomet Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.95 and a Current Ratio set at 1.96.
Earnings per share (EPS) analysis for Zimmer Biomet Holdings Inc [ZBH] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ZBH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Zimmer Biomet Holdings Inc go to 7.24%.
Zimmer Biomet Holdings Inc [ZBH]: Institutional Ownership
The top three institutional holders of ZBH stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2579%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $201.66 billion in ZBH stocks shares; and BERKSHIRE HATHAWAY INC, currently with $177.59 billion in ZBH stock with ownership which is approximately 5.7994%.